In the past week, MLSS stock has gone down by -18.08%, with a monthly decline of -26.15% and a quarterly plunge of -33.33%. The volatility ratio for the week is 8.47%, and the volatility levels for the last 30 days are 5.15% for Milestone Scientific Inc The simple moving average for the last 20 days is -16.90% for MLSS stock, with a simple moving average of -23.88% for the last 200 days.
Is It Worth Investing in Milestone Scientific Inc (AMEX: MLSS) Right Now?
Additionally, the 36-month beta value for MLSS is 0.86. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MLSS is 50.27M and currently, short sellers hold a 0.18% ratio of that float. The average trading volume of MLSS on June 27, 2025 was 64.82K shares.
MLSS) stock’s latest price update
The stock of Milestone Scientific Inc (AMEX: MLSS) has decreased by -5.26 when compared to last closing price of 0.76. Despite this, the company has experienced a -18.08% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-19 that Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments
Analysts’ Opinion of MLSS
Maxim Group, on the other hand, stated in their research note that they expect to see MLSS reach a price target of $1.50, previously predicting the price at $3. The rating they have provided for MLSS stocks is “Buy” according to the report published on November 16th, 2018.
Maxim Group gave a rating of “Buy” to MLSS, setting the target price at $4 in the report published on December 23rd of the previous year.
MLSS Trading at -21.94% from the 50-Day Moving Average
After a stumble in the market that brought MLSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.30% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MLSS starting from BP4 S.r.l., who sale 10,056 shares at the price of $0.90 back on Jun 16 ’25. After this action, BP4 S.r.l. now owns 9,447,183 shares of Milestone Scientific Inc, valued at $9,001 using the latest closing price.
BP4 S.r.l., the 10% Owner of Milestone Scientific Inc, sale 1,693 shares at $0.88 during a trade that took place back on Jun 18 ’25, which means that BP4 S.r.l. is holding 9,445,490 shares at $1,490 based on the most recent closing price.
Stock Fundamentals for MLSS
Current profitability levels for the company are sitting at:
- -1.14 for the present operating margin
- 1.0 for the gross margin
The net margin for Milestone Scientific Inc stands at -0.83. The total capital return value is set at -1.57. Equity return is now at value -88.36, with -51.55 for asset returns.
Based on Milestone Scientific Inc (MLSS), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -8.5.
Currently, EBITDA for the company is -6.72 million with net debt to EBITDA at 0.27. When we switch over and look at the enterprise to sales, we see a ratio of 8.67. The receivables turnover for the company is 12.31for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.94.
Conclusion
In conclusion, Milestone Scientific Inc (MLSS) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
